While neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel as first-line treatment for ERBB2-positive metastatic breast cancer in terms of progression-free survival, the combination was associated with ...
Apr 14, 2016
0
1
Cancers can resist treatment by 'stealing' blood vessels from nearby tissues, a new study shows.
Apr 7, 2016
0
33
A type of breast cancer that often develops resistance to targeted therapies was driven back into remission in mice by a drug that blocks the division of cancer cells, a new study led by researchers at Dana-Farber Cancer ...
Mar 14, 2016
0
93
(HealthDay)—Many women treated for early breast cancer overestimate the odds of it spreading to another organ, and those fears can diminish their quality of life, new research suggests.
Mar 4, 2016
0
24
A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months - working in all subsets of the most common type of breast cancer.
Mar 2, 2016
0
3
(HealthDay)—Exercise does not appear to result in significant improvements in physical functioning in women living with advanced breast cancer, according to a study published online Feb. 12 in Cancer.
Feb 22, 2016
0
1
When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.
Feb 12, 2016
0
208
Boston-A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for the development of future breast cancer ...
Jan 7, 2016
0
20
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The results ...
Dec 30, 2015
0
17
A doctor treating a patient with a potentially fatal metastatic breast tumor would be very pleased to find, after administering a round of treatment, that the primary tumor had undergone a change in character - from aggressive ...
Dec 22, 2015
0
97
